Clinical journal of the American Society of Nephrology : CJASN
Finerenone in People with Chronic Kidney Disease, Type 2 Diabetes, and History of Nephrectomy.
Jair Munoz Mendoza, Matthew R Weir, Stefan D Anker, Gerasimos Filippatos, Peter Rossing, Christiane Ahlers, Meike Brinker, Samuel T Fatoba, Andrea Horvat-Broecker, Katja Rohwedder, Alessia Fornoni, FIDELIO-DKD and FIGARO-DKD Investigators
Published: 202610.2215/CJN.0000000932
Abstract
BACKGROUND: Finerenone significantly reduced the risk of cardiovascular and kidney outcomes in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) in FIDELITY, a prespecified pooled analysis of two phase 3 trials. This post hoc FIDEL…
Preview only. Read the full abstract at the source